| When: |
Thursday 29th April 2010 Registration 8.45am Workshop 9am - 12.30pm. Followed by a light lunch |
|---|---|
| Where: |
Minter Ellison L23, Rialto Tower 525 Collins St Melbourne |
| Speakers: |
Mr Tim Davey Ms Kylie Diwell Ms Janine Pickering |
| Price: |
$350 - members $800 - non-members |
| RSVP: | Monday 26th April, 10am |
Today we find ourselves in a unique position. On the one hand there is an economic crisis resulting in many talented people being on the market and yet in Australia we also have a skills shortage in positions where a high degree of technical training is required. How do you attract the best people to your company? How do you keep your current highly trained staff? How do the changes in the Fair Work Act affect those currently employed in the Biotech industry? What should you be doing to ensure a good working relationship in this challenging environment and not have it deteriorate into an HR or legal battle? Start by strategically planning the employment lifecycle.
The April BioWorkshop will discuss issues that arise at different stages of the employment lifecycle. This workshop aims to address some of the challenges in this fast moving environment and provide practical insights and relevant case studies for discussion including the changes to the Fair Work Act. Tim Davey (Senior associate in Human Resources & Industrial Relations law) and Kylie Diwell (Special Counsel in Intellectual Property law) of Minter Ellison will focus on:
Set up – Getting it right
The contract
• Describing the role
• Flexibility of arrangement
• IP ownership
• Confidentiality obligations
• Conflicts of interest
• Termination provisions
Ongoing management
Effect of the GFC and general obligations
• Changes to an employee's role
• Alternative employment options, including:
• Obligations to re-skill or re-deploy staff
• Directing employees to take leave
• Reducing work hours and/or pay
• Handling retrenchments
• Knowledge capture
Exit arrangements
• Enforcement of rights (including post employment restraints)
• Termination letters
• Monitoring
• Disputes and avoiding litigation
Janine Pickering (HR consultant) will share her vast experience, consulting to Biotechnology companies on HR strategy. She will provide valuable expertise and give practical examples on ‘what works and what hasn’t worked and why.’
Tim specialises in employment and industrial relations, with experience in areas including breach of contract, restraint of trade, wrongful and unlawful termination, unfair dismissal claims, discrimination and equal opportunity, and dispute proceedings in the AIRC under awards and certified agreements.
Tim has particular knowledge in drafting employment contracts, consultancy and contractor agreements, restraint of trade and confidentiality agreements, collective agreements and AWAs. He has advised and represented clients on issues arising from corporate transactions, including due diligence reviews of employment and industrial arrangements, and transmission of business and redundancy issues. He frequently advises on:
• employment and industrial law issues arising from corporate transactions, including due diligence reviews of employment and industrial arrangements and advice on transmission of business and redundancy issues
• management of ill and injured workers, having particular regard to obligations under occupational health and safety, WorkCover, disability discrimination, unlawful termination and unfair dismissal legislation
• review and drafting of employment policies/handbooks, including discipline and termination, EEO and discrimination, internet and email policies.
Kylie has general corporate and commercial experience, as well as specialist expertise in intellectual property, competition and regulatory, technology and communications. Kylie works for both public sector research organisations and private companies in the biotechnology sector .
Kylie frequently advises on:
• intellectual property, including IP licensing arrangements, confidentiality and material transfer agreements and IP due diligence/audits
• joint ventures and other collaborative research vehicles and arrangement (including CRCs)
• general commercial and regulatory issues that arise in biotechnology sector.
Minter Ellison
L23, Rialto Tower
525 Collins St
Melbourne